Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080039 | SCV000111933 | benign | not specified | 2013-08-01 | criteria provided, single submitter | clinical testing | |
Soonchunhyang University Bucheon Hospital, |
RCV000490436 | SCV000267491 | uncertain significance | Primary erythromelalgia | 2016-03-18 | criteria provided, single submitter | reference population | |
Prevention |
RCV000080039 | SCV000309312 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000490436 | SCV000418510 | benign | Primary erythromelalgia | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000375717 | SCV000418511 | benign | Small fiber neuropathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000284177 | SCV000418512 | benign | Paroxysmal extreme pain disorder | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000389941 | SCV000418514 | benign | Channelopathy-associated congenital insensitivity to pain, autosomal recessive | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Labcorp Genetics |
RCV000469131 | SCV000559260 | benign | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000992915 | SCV001145513 | benign | not provided | 2018-12-13 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000992915 | SCV001157147 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV000490436 | SCV001435123 | benign | Primary erythromelalgia | criteria provided, single submitter | research | The heterozygous p.Val991Leu variant in SCN9A has been identified in an individual suspected to have small fibre neuropathy (PMID: 21698661). In vitro functional studies provide some evidence that the p.Pro124Ser variant will not impact protein function (PMID: 21698661). However, these types of assays may not accurately represent biological function. This variant is classified as benign for autosomal dominant small fibre neuropathy because it has been identified in >20% of Latino chromosomes, including 340 homozygotes, by ExAC (http://gnomad.broadinstitute.org/). | |
Gene |
RCV000992915 | SCV001898274 | benign | not provided | 2018-11-08 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25585270, 27956748, 26284228, 27535533, 21698661) |
Unidad de Genómica Garrahan, |
RCV000080039 | SCV005088000 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 21. Only high quality variants are reported. |
Genetic Services Laboratory, |
RCV000080039 | SCV000152672 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Clinical Genetics, |
RCV000080039 | SCV001979183 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000992915 | SCV001979509 | likely benign | not provided | no assertion criteria provided | clinical testing |